Weekly News Wire | June 28, 2021
Medtronic Earns European Approvals For Two Diabetes Management Devices
On May 26, 2021, Medtronic announced it received European approvals for two diabetes management devices, InPen™ and its Guardian™ 4 sensor. InPen is a smart insulin pen for delivering and documenting multiple daily injections. The Guardian™ 4 sensor continuously monitors the user’s glucose levels without finger-sticks for calibration or diabetes treatment decisions. Medtronic plans to launch the two products in European markets starting in third quarter of 2021. The Guardian 4 sensor can be integrated with either the MiniMed™ 780G insulin pump system, or InPen, or for stand-alone continuous glucose monitoring (CGM) use.
In Europe, medical devices . . .
Want To Read More? Log In Or Become A Paid Member
